MongoDB shows bullish technicals but faces weakened fundamentals with declining growth. See why now may be the time to sell ...

Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.

The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...

The Global Vial Adaptors for Reconstitution Drug Market is poised for substantial growth, reflecting strong financial projections and industry expansion.

The Global Vial Adaptors for Reconstitution Drug Market is poised for substantial growth, reflecting strong financial ...

The GBP/JPYgained sharply after upbeat UK GDP data. It hit an intraday high of 1912.82 and is currently trading around 192.78 ...

A new evaluation index system, developed using the Appropriateness Evaluation Protocol (AEP) framework within the Enhanced ...

Tuesday saw the GBP/USD shake off its near-term bearish momentum, cutting off a three-day losing streak and recovering some ...

Shiba Inu price struggles after a 27% drop, but a golden cross may spark a breakout. Key resistance and support levels define its next move.

ADA price struggles to gain momentum as BBTrend remains negative. A breakout above $0.82 could trigger a 67% rally toward $1.16.

PEPETO, PEPE and Mind of PEPE battle for dominance as investors shift focus towards AI and community-driven memecoins in the ...

I would like to extend a warm welcome to Dan Kirby on behalf of the entire Iovance team,” stated Frederick Vogt, Ph.D., J.D., Interim President, Chief Executive Officer and board member of Iovance.